Quantum-Si Incorporated (Nasdaq: QSI) has resolved a listing compliance issue with The Nasdaq Stock Market LLC. On October 14, 2026, the Company received written notification from Nasdaq’s Listing Qualifications Department confirming that it has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Global Market.
The compliance issue stemmed from the Company’s Class A common stock, which had previously fallen below the required $1.00 minimum bid price for 30 consecutive business days. As a result, the Company was given an initial 180-day period to regain compliance. Nasdaq has now determined that the closing bid price of the Company’s common stock has been at or above $1.00 for at least 10 consecutive business days. Consequently, the matter has been closed, and the Company’s listing status is restored.
Quantum-Si is a proteomics company focused on single-molecule protein sequencing. The Company’s platform aims to bring benchtop protein analysis to laboratories, offering real-time kinetic-based detection and dynamic functional protein insights.
